Novo Business Checking Review (2024): Is Novo a Trusted Bank? Your email has been sent You might be wondering if Novo is the right fit for your business? In the following sections we’ll be ...

Novo Holdings is encountering more resistance as it aims to close its $16.5 billion acquisition of pharma manufacturing giant Catalent by the end of the year. A dozen consumer groups and trade ...

US Senator Elizabeth Warren has asked the Federal Trade Commission (FTC) to look into a $16.5 billion deal that would give Novo Nordisk control of manufacturing facilities currently operated by ...

As Novo Holdings hopes to close its $16.5 billion acquisition of CDMO Catalent by the end of the year, the deal is facing a fresh round of lawmaker scrutiny. Wednesday, Sen. Elizabeth Warren ...

Oct 7 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab and Viatris (VTRS.O), opens new tab have agreed to resolve a patent dispute related to Novo's blockbuster weight-loss drugs Ozempic and ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...

Novo Nordisk A/S has fallen behind Eli Lilly & Co. this year in the race to be the big stock market winner from obesity drugs. Analysts expect the Danish company to start catching up. Less than a ...

A coalition of unions, consumer groups and public interest organizations urged the Federal Trade Commission to challenge a $16.5 billion deal in which Novo Nordisk’s parent foundation would ...

Weight loss treatment provider Novo Nordisk has seen a 12% stock price decline in the past month as its challenges grow. Investors were disappointed with results for its new weight loss treatment ...

A new investigation found that such medicines can reduce the risk of Alzheimer's. While this new opportunity will take some time to cook before it's ready to delight shareholders, one of the two ...

Commercial Investments: 6%, adjusted to around 10% excluding legal provisions. Novo Nordisk AS (NYSE:NVO) reported a strong 25% sales growth, with significant contributions from key brands like ...

NEW YORK, Oct 18 (Reuters) - U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, the controlling shareholder of Novo Nordisk ...